?:authorAffiliation
|
-
[\'Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy. Electronic address: giuseppe.curigliano@ieo.it.\', \'Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal; Nova Medical School, Lisbon, Portugal.\', \'Iridium Kankernetwerk, Department of Radiation Oncology, Wilrijk-Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium.\', \'Breast Surgery, San Raffaele University and Research Hospital, Milano, Italy.\', \'Istituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy.\', \'Faculty of Medicine and Health, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.\', \'Service Interdisciplinaire de Cancérologie, Hopital Riviera-Chablais, Rennaz, Vaud, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Switzerland.\', \'Medical University of Gdansk, Gdansk, Poland.\', \'Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal.\']
|